Blinatumomab for Acute Lymphoblastic Leukaemia (ALL)

Blinatumomab is a monoclonal antibody. Its monoclonal antibodies target the CD19 proteins on the surface of your leukaemia cells. This stimulates your immune system to destroy the leukaemia cells. If you have any questions about this ALL treatment - this booklet covers the basics for you.

Please note - this is a digital download only and you will not receive a hardcopy through the post. 

Digital downloads

To access an instant download of our Blinatumomab for Acute Lymphoblastic Leukaemia (ALL) information booklet, please click here (opens as a PDF file). 

Each booklet takes us approximately six months to write and is supplied free of charge to patients, families and hospitals across the UK. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can.